Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies. (PubMed, Prostate Cancer Prostatic Dis) - Dec 29, 2024 - "Ferroptosis can serve as a potential therapeutic target for CRPC, and could be a new strategy for combination therapy. Moreover, ferroptosis-related genes may be great indicators of PCa prognosis. Further research on ferroptosis in CRPC therapy can benefit from the frameworks provided by this review."
Journal • Review • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor • AMPK • DECR1 • GPX4 • SLC7A11
|
|
Feng Lyu; Huizhu Chen; Xianshu Gao
|